Medpace Holdings Total Current Assets 2014-2026 | MEDP

Medpace Holdings total current assets from 2014 to 2026. Total current assets can be defined as the sum of all assets that are classified as current because they will provide a benefit within one year.
  • Medpace Holdings total current assets for the quarter ending March 31, 2026 were $0.990B, a 3.85% decline year-over-year.
  • Medpace Holdings total current assets for 2025 were $0.99B, a 3.85% decline from 2024.
  • Medpace Holdings total current assets for 2024 were $1.029B, a 73.32% increase from 2023.
  • Medpace Holdings total current assets for 2023 were $0.594B, a 77.81% increase from 2022.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
Medpace Holdings Annual Total Current Assets
(Millions of US $)
2025 $990
2024 $1,029
2023 $594
2022 $334
2021 $691
2020 $474
2019 $317
2018 $178
2017 $130
2016 $133
2015 $95
2014 $133
2013
Medpace Holdings Quarterly Total Current Assets
(Millions of US $)
2025-12-31 $990
2025-09-30 $737
2025-06-30 $521
2025-03-31 $821
2024-12-31 $1,029
2024-09-30 $1,033
2024-06-30 $873
2024-03-31 $745
2023-12-31 $594
2023-09-30 $449
2023-06-30 $379
2023-03-31 $368
2022-12-31 $334
2022-09-30 $338
2022-06-30 $329
2022-03-31 $356
2021-12-31 $691
2021-09-30 $641
2021-06-30 $550
2021-03-31 $533
2020-12-31 $474
2020-09-30 $395
2020-06-30 $319
2020-03-31 $303
2019-12-31 $317
2019-09-30 $250
2019-06-30 $194
2019-03-31 $182
2018-12-31 $178
2018-09-30 $153
2018-06-30 $158
2018-03-31 $154
2017-12-31 $130
2017-09-30 $117
2017-06-30 $123
2017-03-31 $128
2016-12-31 $133
2016-09-30 $121
2016-06-30
2016-03-31
2015-12-31
2015-09-30
2014-12-31 $133
2013-12-31
Sector Industry Market Cap Revenue
Medical Medical Services $14.094B $2.530B
Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization which provides Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $134.187B 24.31
HCA Healthcare (HCA) United States $110.772B 17.53
CVS Health (CVS) United States $101.670B 11.75
Elevance Health (ELV) United States $68.432B 10.33
Cencora (COR) United States $62.409B 19.63
Natera (NTRA) United States $27.358B 0.00
Labcorp Holdings (LH) United States $21.501B 15.87
DiDi Global (DIDIY) China $18.026B 15.96
Viatris (VTRS) United States $15.685B 5.71
EUROFINS SCIENT (ERFSF) Luxembourg $14.535B 0.00
BioMerieux (BMXMF) France $12.476B 0.00
Solventum (SOLV) United States $11.408B 10.78
Revvity (RVTY) United States $10.039B 17.71
BrightSpring Health Services (BTSG) United States $8.774B 43.59
Charles River Laboratories (CRL) United States $8.667B 17.09
ICON (ICLR) Ireland $8.626B 8.56
CochLear (CHEOY) Australia $8.030B 0.00
Sonic Healthcare (SKHHY) Australia $6.905B 0.00
HealthEquity (HQY) United States $6.586B 23.20
Bausch + Lomb (BLCO) Canada $5.877B 32.98
GETINGE (GNGBY) Sweden $5.626B 17.96
Avantor (AVTR) United States $5.388B 8.68
PACS (PACS) United States $5.304B 27.44
Caris Life Sciences,�Inc (CAI) United States $5.101B 0.00
Sotera Health (SHC) United States $4.380B 19.95
Alignment Healthcare (ALHC) United States $4.188B 0.00
Concentras Parent (CON) United States $2.818B 16.12
Organon (OGN) United States $2.299B 2.57
Amplifon S.p.A (AMFPF) Italy $2.275B 13.27
Pediatrix Medical (MD) United States $1.782B 11.11
Establishment Labs Holdings (ESTA) United States $1.765B 0.00
GeneDx Holdings (WGS) United States $1.746B 42.28
Surgery Partners (SGRY) United States $1.671B 41.65
Sonida Senior Living (SNDA) United States $1.544B 0.00
Ardent Health (ARDT) United States $1.345B 5.70
Progyny (PGNY) United States $1.277B 25.08
Ryman Healthcare (RYHTY) New Zealand $1.240B 0.00
InnovAge Holding (INNV) United States $1.113B 164.00
Teladoc Health (TDOC) United States $0.920B 0.00
CareDx (CDNA) United States $0.822B 0.00
GoodRx Holdings (GDRX) United States $0.750B 12.17
Enhabit (EHAB) United States $0.709B 25.89
Nutex Health (NUTX) United States $0.704B 11.25
Omada Health (OMDA) United States $0.672B 0.00
QDM (QDMI) Hong Kong, SAR China $0.604B 99.85
COMPASS Pathways (CMPS) United Kingdom $0.531B 0.00
Embecta (EMBC) United States $0.524B 2.92
Charming Medical (MCTA) Hong Kong, SAR China $0.497B 0.00
CryoPort (CYRX) United States $0.482B 0.00
Auna S.A (AUNA) Luxembourg $0.435B 4.70
SBC Medicals (SBC) United States $0.426B 8.47
Forward Industries (FWDI) United States $0.375B 0.00
Strata Critical Medical (SRTA) United States $0.349B 0.00
Agilon Health (AGL) United States $0.316B 0.00
Shoulder Innovations (SI) United States $0.309B 0.00
Oncology Institute (TOI) United States $0.304B 0.00
So-Young (SY) China $0.262B 0.00
LifeMD (LFMD) United States $0.166B 0.00
Biodesix (BDSX) United States $0.133B 0.00
Beauty Health (SKIN) United States $0.115B 0.00
Ascend Wellness Holdings (AAWH) United States $0.091B 0.00
Park Dental Partners (PARK) United States $0.080B 0.00
Sera Prognostics (SERA) United States $0.077B 0.00
DocGo (DCGO) United States $0.051B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.037B 0.00
Pomdoctor - (POM) China $0.031B 0.00
IceCure Medical (ICCM) Israel $0.026B 0.00
OSR Holdings (OSRH) United States $0.018B 0.00
SeaStar Medical Holding (ICU) United States $0.015B 0.00
Basel Medical Group (BMGL) Singapore $0.011B 0.00
Lifeward (LFWD) United States $0.010B 0.00
XWELL (XWEL) United States $0.009B 0.00
Aclarion (ACON) United States $0.007B 0.00
Synergy CHC (SNYR) United States $0.007B 0.00
Pheton Holdings (PTHL) China $0.006B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
Co-Diagnostics (CODX) United States $0.005B 0.00
Intelligent Bio Solutions (INBS) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
INVO Fertility (IVF) United States $0.003B 0.00
NewGenIvf Group (NIVF) Thailand $0.001B 0.00
Cano Health (CANOQ) United States $0.000B 0.00